[1] |
ZHONG Ya’nan, YOU Xuemei, DI Haili, MENG Lin, SUN Lingling.
The Value of Serum Cathepsin L Level Combined
with ABCD3-I Score in Predicting the Short-Term of
Cerebral Infarction of TIA Patients
[J]. Chinese Journal of Stroke, 2024, 19(9): 1034-1039.
|
[2] |
ZHANG Jiancun, WANG Xinxing, TONG Haibo.
Research Progress on the Role of Platelet Activation in Acute Cerebral Infarction
[J]. Chinese Journal of Stroke, 2024, 19(5): 579-585.
|
[3] |
YANG Lin, ZHANG Yonghai, XIE Luling, XIE Chun, LANG Xiaomei, WANG Runqiang.
CTA Combined with Clinical Characteristics to Predict the Risk of Cerebral Infarction in TIA Patients with Head and Neck Atherosclerosis at Middle and High Altitude Areas
[J]. Chinese Journal of Stroke, 2024, 19(2): 173-180.
|
[4] |
JIANG Xiaoqing, LI Zixiao, WANG Yongjun.
Progress in Clinical Research of Medical Quality Improvement in Stroke
[J]. Chinese Journal of Stroke, 2024, 19(2): 227-234.
|
[5] |
XIN Na, LIN Lin, BAI Bo, TIAN Zhaozeng, JIANG Jialin, WANG Tao.
Research and Application of Clinical Decision Support System for Acute Cerebral Infarction Diagnosis Coding
[J]. Chinese Journal of Stroke, 2024, 19(11): 1313-1320.
|
[6] |
HUANG Yanling, YANG Liu, YUAN Dezhi, WANG Xuefei, WANG Hui, MENG Tao.
Effects of Probucol Combined with Atorvastatin Calcium in the Treatment of Acute Cerebral Infarction
[J]. Chinese Journal of Stroke, 2024, 19(10): 1143-1147.
|
[7] |
WANG Jiwei, LI Hui, LIU Jianfeng, XU Lifeng, BI Hongling, XIE Xiongwei, TIAN Yangyang.
Study on the Value of YKL-40 and Caspase-1 Levels and ASPECTS in Predicting the Prognosis of Patients with Anterior Circulation Massive Cerebral Infarction after Interventional Thrombectomy
[J]. Chinese Journal of Stroke, 2024, 19(10): 1155-1161.
|
[8] |
YANG Xin, ZHANG Jing, LI Zixiao, WANG Yongjun.
Construction and Development of Quality Control Indicator System for Single Disease
[J]. Chinese Journal of Stroke, 2024, 19(1): 22-27.
|
[9] |
The Cerebrovascular Disease Working Group of National Center for Healthcare Quality Management in Neurological Diseases.
Medical Quality Control Indicators for Cerebral Infarction (2020 Edition)
[J]. Chinese Journal of Stroke, 2024, 19(1): 35-43.
|
[10] |
The Cerebrovascular Disease Working Group of National Center for Healthcare Quality Management in Neurological Diseases.
Medical Quality Control Indicators for Intracerebral Hemorrhage
[J]. Chinese Journal of Stroke, 2024, 19(1): 44-49.
|
[11] |
LU Lu, XIONG Weixi, ZHOU Dong.
The Construction of the Medical Quality Control System for Epilepsy and Convulsive Status Epilepticus
[J]. Chinese Journal of Stroke, 2024, 19(1): 55-57.
|
[12] |
The Epilepsy Working Group of National Center for Healthcare Quality Management in Neurological Diseases.
Medical Quality Control Indicators for Epilepsy and Convulsive Status Epilepticus
[J]. Chinese Journal of Stroke, 2024, 19(1): 58-65.
|
[13] |
HE Ji, FAN Dongsheng.
Establish a Medical Standard and Continuous Quality Improvement System for Motor Neuron Disease in China
[J]. Chinese Journal of Stroke, 2024, 19(1): 66-68.
|
[14] |
The Motor Neuron Disease Working Group of National Center for Healthcare Quality Management in Neurological Diseases.
Medical Quality Control Indicators for Amyotrophic Lateral Sclerosis
[J]. Chinese Journal of Stroke, 2024, 19(1): 69-75.
|
[15] |
LIU Xudong, LIU Meng, SU Ying, ZHOU Yanxia, REN Lijie.
Current Research in the Mechanism and Clinical Application about Remote Ischemic Preconditioning in Cerebral Infarction
[J]. Chinese Journal of Stroke, 2024, 19(1): 105-111.
|